Tissue biopsy allowing histological classification is essential for defining the optimal management of patients with nonHodgkin's lymphoma. It is necessary for establishing a diagnosis, contributing information about natural history, responsiveness to therapy and prognosis. Repeat biopsy may be required to confirm relapse or progression of disease, especially when transformation of follicular lymphoma to high grade histology is suspected (Cullen et al., 1979; Hubbard et al., 1982; Gallagher et al., 1986) , and to define the nature of radiological abnormalities remaining after therapy. Immunocytochemical analysis is an important adjunct to morphological diagnosis but requires extra tissue. Furthermore, certain differentiation antigens can only be detected using fresh tissue (Cossman et al., 1984; Pallesen, 1988) .
The mainstay of tissue diagnosis in lymphoma is excision biopsy of peripheral lymph nodes. In the absence of palpable disease, resort has been made to more invasive methods such as laparotomy and mediastinotomy but these require general anaesthesia, carry significant morbidity, and are expensive and time consuming. In patients with intra-abdominal and mediastinal disease, guided needle biopsy may offer an alternative. However, in the past, this technique has been limited to providing cytological material only and therefore has been of limited application in lymphoma where morphological accuracy requires more substantial tissue, particularly to determine nodularity (Zornoza et al., 1981; Buscarini et al., 1985; Pontifex & Klimo, 1984; Webb et al., 1989 (Haaga, 1979; Staab et al., 1979; Husband & Golding, 1983; Ferrucci et al., 1980) . Several authors have reported the use of guided biopsy in patients with Hodgkin's disease and non-Hodgkin's lymphoma, in particular using fine needle aspiration to provide material for cytological analysis (Zornoza et al., 1981; Buscarini et al., 1985; Pontifex & Klimo, 1984; Webb et al., 1989) . The latter technique has the potential advantage of speed in making a diagnosis in the gravely ill patient but rarely provides adequate morphological information to fully characterise non-Hodgkin's lymphomas;
importantly, nodularity is difficult to determine. Immunocytochemistry is also less satisfactory. Haaga first described the use of a cutting needle for retroperitoneal biopsies, but in his series of 29 cases only four were lymphomas, two of which were successfully diagnosed (Haaga, 1979) . Others have compared the use of fine needle with cutting needle biopsies and shown an advantage for the latter in the diagnosis and classification of lymphomas in addition to other benign and malignant conditions (Haaga et al., 1983; Erwin et al., 1986; Goralnik et al., 1988; Jennings et al., 1989; Knelson et al., 1989 ). Lindgren's development of a hand-held device for automatically firing a Tru-cut needle (Travenol Laboratories) represented a major advance, allowing precise control with consequent better specimen size and preservation (Lindgren, 1982) . In particular, the speed of sampling with this device avoids the shearing artefact which limited interpretation of needle biopsies obtained by conventional methods. Wotherspoon et al. (1989) (Tani et al., 1988; Liliemark et al., 1989) This series relates primarily to patients requiring biopsy at the time of recurrence rather than patients at first presentation reflecting the referral pattern at this centre, in that patients are usually seen when the primary diagnosis has been made and a stringent policy of re-biopsy at relapse is followed, particularly in patients with follicular lymphoma. Detection of histological transformation at relapse is invaluable, allowing early adjustment of treatment with the potential for improving the currently poor prognosis in this group of patients (Gallagher et al., 1986 on the preference of the radiologist and availability of equipment, at this centre, CT being considered preferable for visualising the retro-peritoneum.
In summary, core needle biopsy using the Biopty Gun has major value in the clinical management of non-Hodgkin's lymphoma, providing a safe, quick and reliable alternative to surgical tissue sampling without compromising lymphoma characterisation. However, it requires particular expertise from the radiologist and pathologist to both obtain and interpret the small specimens. Furthermore, negative results may require further clarification. More experience is needed to define the place of core needle biopsy in mediastinal and thoracic inlet disease when the potential risk of haemorrhage and contrast-induced bronchospasm may outweigh the advantages. In the absence of peripheral lymphadenopathy, it is now the procedure of choice for histological sampling of abdominal disease in non-Hodgkin's lymphoma.
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